Description

Centene Corporation’s Medicaid Reset Is Working—Here’s What’s Quietly Driving Margin Stability!

Centene Corporation reported a fourth quarter 2025 adjusted diluted loss per share of $1.19, leading to a full-year adjusted diluted EPS of $2.08, slightly exceeding prior expectations despite a challenging year. The company highlighted improvements in Medicaid profitability, a key business segment, with a fourth quarter health benefits ratio (HBR) improving to 93.0%, reflecting sequential progress from earlier quarters. Medicaid guidance anticipates stable margins in 2026, supported by a composite rate increase of approximately 5.5% above 2024 levels and a net trend expectation around the mid-4% range. Management cited continuing efforts to control costs through network optimization, clinical program enhancements, fraud reduction, and collaborations with state partners, especially in behavioral health where outlier care patterns were identified and addressed.